This announcement is a separate document:
創美藥業：（1）建議委任執行董事；（2）建議委任非執行董事；（3）建議修訂章程；及（4）2022年第二次臨時股東大會通告
Charmacy Pharmaceutical: (1) PROPOSED APPOINTMENT OF AN EXECUTIVE DIRECTOR; (2) PROPOSED APPOINTMENT OF A NON-EXECUTIVE DIRECTOR; (3)PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.